Nordea's Q2 results largely came in as expected. Credit drove a small beat on the bottom line, though the bank's main pre-provision lines were all within 1-2% of consensus. While the above means that ...
Cognition Therapeutics (NASDAQ:CGTX), a clinical-stage biotechnology firm focused on developing therapies for neurodegenerative diseases, released its earnings for Q2 2025 on August 7, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback